跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
IMULDOSA - Health Canada Drug Approval Details
Approvals
/
Health Canada
/
IMULDOSA
Authorized
STANDARD
IMULDOSA
Accord Healthcare Inc
🇨🇦 Health Canada
Approval Date
Mar 30, 2026
Approval ID
1d426923156bcd15
Company
Accord Healthcare Inc
Type
Standard
Approval Details
Approval Id
1d426923156bcd15
Drug Approval Canada Name
IMULDOSA
Product Name
IMULDOSA
Status
Approved
Status Date
2026-01-21
Drug Class
Human
Dosage Form
Solution
Route Of Administration
Subcutaneous
Schedule
SCHEDULE D , PRESCRIPTION
Ahfs
90:24.20.92
Atc Original
L04AC05 USTEKINUMAB
Aig Number
0152506001
Company Name
Accord Healthcare Inc
Company Address
3535 Boulevard St-Charles, Suite 704 Kirkland Quebec Canada H9H 5B9
Company Detail Path
/organization/accord-healthcare-inc
Company Information
Pharmaceutical Company Name
Accord Healthcare Inc
Country Name
Canada
Province Name
Quebec
City Name
kirkland,quebec,country_ca
Address
704-3535 boul Saint-Charles
Authorized
Quick Info
Agency
Health Canada
Country
🇨🇦
Approval Date
Mar 30, 2026
Approval ID
1d426923156bcd15
Type
Standard
Back to Health Canada Approvals